Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 3 2013
The Biotechnology Industry Organization (BIO) today wrote leaders of the House and Senate Agricultural Committees urging reauthorization and mandatory...
May 2 2013
Washington, D.C. (May 2, 2013) The Biotechnology Industry Organization (BIO) today expressed concern over specific foreign government's weak intellectual...
May 1 2013
Key members of the U.S. agricultural value chain have joined together to applaud the work of the United States and like-minded governments to promote the...
Apr 30 2013
The Biotechnology Industry Organization (BIO) today submitted comments to the House Energy & Commerce Committee’s Bipartisan Review of the...
Apr 29 2013
Technology Makes Better Nutrition Available in a Sustainable Way  Following a thorough and rigorous regulatory process spanning more than two decades...
Apr 25 2013
The Biotechnology Industry Organization (BIO) today applauded the introduction of the Master Limited Partnership Parity Act, authored by Sen. Chris Coons (D-...
Apr 25 2013
Chicago, Illinois (April 25, 2013) - The 2013 BIO International Convention, the global event for biotechnology, wrapped up today at McCormick Place in...
Apr 24 2013
"Although we haven't seen the language of the proposed bill, it's important to note that the biotech industry does not oppose food labeling....
Apr 24 2013
The Biotechnology Industry Organization (BIO) today welcomed new members Calysta Energy, American Science and Technology Corporation, LanzaTech, The Coca-...


Biotechnology News

September 2, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

September 2, 2014

NEW YORK--(BUSINESS WIRE)--David R. Guyer, M.D., CEO of Ophthotech Corp. will present an overview of the Company at the Morgan Stanley Global Healthcare Conference in New...

September 2, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the closing of a $16 million Series B financing to fund continued development of its proprietary...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal...

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman...